Search Results - Jonathan M. Loree

Refine Results
  1. 1

    Recent developments in the treatment of metastatic colorectal cancer by Jonathan M. Loree, Scott Kopetz

    Published in Therapeutic Advances in Medical Oncology (2017-08-01)
    Get full text
    Article


  2. 2

    Impact of grade on workup of rectal neuroendocrine tumors: a retrospective cohort study by Akie Watanabe, Sabrina Rai, Lily Yip, Carl J. Brown, Jonathan M. Loree, Heather C. Stuart

    Published in World Journal of Surgical Oncology (2024-04-01)
    Get full text
    Article


  3. 3

    Tumor Biomarker Testing for Metastatic Colorectal Cancer: a Canadian Consensus Practice Guideline by Irene S. Yu, Francine Aubin, Rachel Goodwin, Jonathan M. Loree, Cheryl Mather, Brandon S. Sheffield, Stephanie Snow, Sharlene Gill

    Published in Therapeutic Advances in Medical Oncology (2022-07-01)
    Get full text
    Article


  4. 4

    Colorectal Cancer and Onset of Anxiety and Depression: A Systematic Review and Meta-Analysis by Vicki Cheng, Niki Oveisi, Helen McTaggart-Cowan, Jonathan M. Loree, Rachel A. Murphy, Mary A. De Vera

    Published in Current Oncology (2022-11-01)
    Get full text
    Article


  5. 5

    Canadian Colorectal Cancer Screening Guidelines: Do They Need an Update Given Changing Incidence and Global Practice Patterns? by Anastasia Kalyta, Mary A. De Vera, Stuart Peacock, Jennifer J. Telford, Carl J. Brown, Fergal Donnellan, Sharlene Gill, Jonathan M. Loree

    Published in Current Oncology (2021-04-01)
    Get full text
    Article


  6. 6

    Mental healthcare utilisation among individuals with colorectal cancer: population-based cohort studies by Eric C Sayre, Mary A De Vera, Alyssa Howren, Rachel A Murphy, Jonathan M Loree, Vicki Cheng, Vienna Cheng, Sharlene Gill

    Published in BMJ Oncology (2025-04-01)
    Get full text
    Article


  7. 7

    Mental health in people living with and beyond colorectal cancer: A patient‐oriented constructivist grounded theory by Vicki Cheng, Helen McTaggart‐Cowan, Jonathan M. Loree, Rachel A. Murphy, Mikaela Barnes, Haydn Bechthold, Norman Jansen, Mary A. De Vera

    Published in Cancer Medicine (2024-09-01)
    Get full text
    Article


  8. 8

    Virtual Oncology Appointments during the Initial Wave of the COVID-19 Pandemic: An International Survey of Patient Perspectives by Jonathan M. Loree, Hallie Dau, Nevena Rebić, Alyssa Howren, Louise Gastonguay, Helen McTaggart-Cowan, Sharlene Gill, Kanwal Raghav, Mary A. De Vera

    Published in Current Oncology (2021-01-01)
    Get full text
    Article


  9. 9

    Direct medical costs of young-onset colorectal cancer: a worldwide systematic review by Ria Garg, Vicki Cheng, Ursula Ellis, Vanay Verma, Helen McTaggart-Cowan, Stuart Peacock, Jonathan M. Loree, Mohsen Sadatsafavi, Mary A. De Vera

    Published in BMC Health Services Research (2022-08-01)
    Get full text
    Article


  10. 10

    Efficacy and Prognostic Factors for Y-90 Radioembolization (Y-90) in Metastatic Neuroendocrine Tumors with Liver Metastases by Erica S. Tsang, Jonathan M. Loree, Janine M. Davies, Sharlene Gill, David Liu, Stephen Ho, Daniel J. Renouf, Howard J. Lim, Hagen F. Kennecke

    Get full text
    Article


  11. 11

    Symptom Burden and Time from Symptom Onset to Cancer Diagnosis in Patients with Early-Onset Colorectal Cancer: A Multicenter Retrospective Analysis by Victoria A. Baronas, Arif A. Arif, Eric Bhang, Gale K. Ladua, Carl J. Brown, Fergal Donnellan, Sharlene Gill, Heather C. Stuart, Jonathan M. Loree

    Published in Current Oncology (2024-04-01)
    Get full text
    Article


  12. 12

    Reply to Torlakovic, E.; Normanno, N. Comment on “Bisson et al. Novel Approach to Proficiency Testing Highlights Key Practice Variations in Cancer Biomarker Delivery. <i>J. Mol. Pa... by Brandon S. Sheffield, Kassandra R. Bisson, Andrea Beharry, Michael D. Carter, Shaan Dudani, Jonathan M. Loree, Stephanie Snow, Jennifer R. Won, Stephen Yip, John G. Garratt

    Published in Journal of Molecular Pathology (2024-06-01)
    Get full text
    Article


  13. 13

    Genomic and transcriptomic landscapes of metastatic neuroendocrine neoplasms from distinct primary sites and their clinical implications by Kathleen Wee, Kevin C. Yang, David F. Schaeffer, Chen Zhou, Emily Leung, Xiaolan Feng, Janessa Laskin, Marco A. Marra, Jonathan M. Loree, Sharon M. Gorski

    Published in Scientific Reports (2025-05-01)
    Get full text
    Article


  14. 14

    Dual PET Imaging with [<sup>68</sup>Ga]Ga-DOTA-TOC and [<sup>18</sup>F]FDG to Localize Neuroendocrine Tumors of Unknown Origin by Ali Zaidi, Pavithraa Ravi, Ingrid Bloise, Sara Harsini, Heather C. Stuart, Hagen F. Kennecke, Ian Alberts, François Bénard, Don Wilson, Patrick Martineau, Jonathan M. Loree

    Published in Current Oncology (2025-09-01)
    Get full text
    Article


  15. 15

    Novel Approach to Proficiency Testing Highlights Key Practice Variations in Cancer Biomarker Delivery by Kassandra R. Bisson, Jennifer R. Won, Andrea Beharry, Michael D. Carter, Shaan Dudani, John G. Garratt, Jonathan M. Loree, Stephanie Snow, Stephen Yip, Brandon S. Sheffield

    Published in Journal of Molecular Pathology (2024-01-01)
    Get full text
    Article


  16. 16

    The clinical impact of COVID-19 on patients with cancer in British Columbia: An observational study by Angela S. Mathews, Ashley Paul, Irene S. Yu, Colleen McGahan, Eric Bhang, Diego Villa, Karen Gelmon, Antonio Avina-Zubieta, Alina S. Gerrie, Ursula Lee, Stephen Chia, Ryan R. Woods, Jonathan M. Loree

    Published in Heliyon (2022-12-01)
    Get full text
    Article


  17. 17

    Effect of Immunosuppressive or Immunomodulatory Agents on Severe COVID‐19 Outcomes: A Population‐Based Cohort Study by Shelby Marozoff, Jeremiah Tan, Na Lu, Ayesha Kirmani, Jonathan M. Loree, Hui Xie, Diane Lacaille, Jacek A. Kopec, John M. Esdaile, Bonnie Corradetti, Peter Malone, Cheryl L. Koehn, Philippa Mennell, Alison M. Hoens, J. Antonio Aviña‐Zubieta

    Published in ACR Open Rheumatology (2023-12-01)
    Get full text
    Article


  18. 18

    Pathologic complete response after neoadjuvant therapy for locally advanced rectal cancer in a real-world setting: a population-based study by Lina Cadili, Jonathan M. Loree, Michael Peacock, Kimberly DeVries, Amandeep Ghuman, Amandeep Ghuman, Ahmer A. Karimuddin, Ahmer A. Karimuddin, P. Terry Phang, P. Terry Phang, Manoj J. Raval, Manoj J. Raval, Carl J. Brown, Carl J. Brown

    Published in Frontiers in Oncology (2025-05-01)
    Get full text
    Article


  19. 19

    Optimizing the number of variants tracked to follow disease burden with circulating tumor DNA assays in metastatic colorectal cancer by Mélina Boutin, James T. Topham, Harriet Feilotter, Hagen F. Kennecke, Félix Couture, Mohammed Harb, Peter Kavan, Scott Berry, Howard J. Lim, John R. Goffin, Chaudhary Ahmad, Anthony Lott, Daniel J. Renouf, Derek J. Jonker, Dongsheng Tu, Chris J. O’Callaghan, Eric X. Chen, Jonathan M. Loree

    Published in Therapeutic Advances in Medical Oncology (2023-06-01)
    Get full text
    Article


  20. 20

    Plasma arginine as a predictive biomarker for outcomes with immune checkpoint inhibition in metastatic colorectal cancer: a correlative analysis of the CCTG CO.26 trial by Christopher O’Callaghan, Scott Berry, Petr Kavan, Jonathan M Loree, Felix Couture, Dongsheng Tu, Sheryl Koski, Lucy X Ma, Emma Titmuss, Derek J Jonker, Hagen F Kennecke, Chaudhary E Ahmad, John R Goffin, Mohammed Harb, Bruce Colwell, Setareh Samimi, Benoit Samson, Tahir Abbas, Nathalie Aucoin, Francine Aubin, Eric X Chen

    Published in Journal for ImmunoTherapy of Cancer (2024-12-01)
    Get full text
    Article


Search Tools: